Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Hurni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Medical Virology|February 1, 1990
Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccineW M Hurni, R R Roehm, W J Miller
Annals of the New York Academy of Sciences|September 20, 1993
Anti-hepatitis A in the general population and in hepatitis A vaccinees using saliva and serum as diagnostic mediaW M Hurni, D Laufer, W J Miller, et al.
Journal of Immunological Methods|December 15, 1991
Detection of antibody to the PreS2 sequence of the hepatitis B virus envelope protein using an immuno-ligand assay with a silicon sensor detection systemW M Hurni, W J Miller, R F Zuk, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1984
Viral enhancement and interference induced in cell culture by hepatitis A virus: application to quantitative assays for hepatitis A virusW M Hurni, W J Miller, W J McAleer, et al.
Journal of Biological Standardization|July 1, 1983
Automated cytopathic effect (CPE) assaysW J McAleer, W J Miller, W M Hurni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition siteT R Cupps, J Tibbles, W M Hurni, et al.
Peptides|September 1, 1987
Isolation of multiple biologically and chemically diverse species of epidermal growth factorM W Riemen, R J Wegrzyn, A E Baker, et al.
Vaccine|August 1, 1994
Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylationP J Kniskern, A Hagopian, P Burke, et al.
Biochemistry|March 19, 2003
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAbG B McGaughey, M Citron, R C Danzeisen, et al.
Protein Expression and Purification|December 22, 1999
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiaeJ C Cook, J G Joyce, H A George, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medical Virology|February 1, 1990
Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccineW M Hurni, R R Roehm, W J Miller
Annals of the New York Academy of Sciences|September 20, 1993
Anti-hepatitis A in the general population and in hepatitis A vaccinees using saliva and serum as diagnostic mediaW M Hurni, D Laufer, W J Miller, et al.
Journal of Immunological Methods|December 15, 1991
Detection of antibody to the PreS2 sequence of the hepatitis B virus envelope protein using an immuno-ligand assay with a silicon sensor detection systemW M Hurni, W J Miller, R F Zuk, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1984
Viral enhancement and interference induced in cell culture by hepatitis A virus: application to quantitative assays for hepatitis A virusW M Hurni, W J Miller, W J McAleer, et al.
Journal of Biological Standardization|July 1, 1983
Automated cytopathic effect (CPE) assaysW J McAleer, W J Miller, W M Hurni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition siteT R Cupps, J Tibbles, W M Hurni, et al.
Peptides|September 1, 1987
Isolation of multiple biologically and chemically diverse species of epidermal growth factorM W Riemen, R J Wegrzyn, A E Baker, et al.
Vaccine|August 1, 1994
Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylationP J Kniskern, A Hagopian, P Burke, et al.
Biochemistry|March 19, 2003
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAbG B McGaughey, M Citron, R C Danzeisen, et al.
Protein Expression and Purification|December 22, 1999
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiaeJ C Cook, J G Joyce, H A George, et al.
Pageof 2